Home›Methandrostenolone

Methandrostenolone

5 interactions on record

Methandrostenolone has 5 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Fludrocortisone Acetate, Nateglinide. Patients taking Methandrostenolone should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 5
Moderate: 2

Moderate (2)

Methandrostenolone + Fludrocortisone Acetate— Enhanced tendency toward edema. Use caution, especially in patients with hepatic or cardiac disease.
Methandrostenolone + Nateglinide— Anabolic hormone that may increase blood-glucose-lowering effect of nateglinide and susceptibility to hypoglycemia.

Methandrostenolone + Fludrocortisone Acetate🟡Moderate

Enhanced tendency toward edema. Use caution, especially in patients with hepatic or cardiac disease.

Methandrostenolone + Nateglinide🟡Moderate

Anabolic hormone that may increase blood-glucose-lowering effect of nateglinide and susceptibility to hypoglycemia.

Methandrostenolone + Esterified Estrogens, Methyltestosteroneℹ️Unknown

Drug Interactions (Androgens) Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants.

Methandrostenolone + Methyltestosteroneℹ️Unknown

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants.

Methandrostenolone + Testosterone Enanthateℹ️Unknown

Drug Interactions When administered concurrently, the following drugs may interact with androgens: Anticoagulants, oral – C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirement.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.